Signals mentioning HUL
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000 cr nutraceuticals market
- Honasa buys 58% of Fluence Pharma at ₹135 cr EV, enters ₹16,000-cr nutraceuticals category
- Premium RTD beverages break out of metros as Tier-2 and Tier-3 India fuel new demand
- Dabur, Emami, Parle signal no MRP cuts despite crude slipping below $80/barrel
- FMCG distribution moat erodes as ONDC, quick commerce flatten route-to-market
- Brokerages reset consumer playbook: Citi Neutral on Titan, JPM Overweight USL, Macquarie backs Trent & Devyani
- HUL, Dabur shrink packs as shrinkflation grips FMCG: Pears 60g→57g, Vatika sachet 4ml→3.8ml
- Haleon commits Rs 2,000 cr for first India plant at Pithampur, online by 2029-30
- India FMCG holds firm against Iran war, inflation; firms hike prices 3-8% as Crisil eyes 8-10% FY27 growth
- Dabur claims #2 oral care slot in Modern Trade as Gel surges 50%+ and Meswak rides Nagarjuna push
- HUL trims permanent headcount 10.7% to 5,898 in FY26 even as it commits Rs 2,000 cr capex
- Consumer deal volumes climb 22% but values crash 63% to $1.4bn as investors turn picky
- Trent eyes 10x revenue runway as Zudio, Westside scale to 1,286 stores across 321 cities
- Indians redirect spend to travel, concerts, iPhones as Nilesh Shah flags experience-led consumption shift
- Kotak MF: Apple India FY26 revenue set to double HUL's as premium spend outpaces mass
- Kotak MF: Premium spending surges as mass consumption lags; Apple India FY26 revenue seen at 2x HUL
- Indians' ₹1.45L cr foreign travel spend now dwarfs building materials industry: Kotak MF's Nilesh Shah
- Dabur says Gulf war inflation erodes GST cut gains, forces 4% price hike